饱和砂土基于相变状态的不排水本构模型

饱和砂土基于相变状态的改进本构模型能较好地描述砂土不排水情况下的应力-应变关系。通过改进模型中相变状态参量的计算方法,将e-lgp°表达式加以改进,通过详细的阐述,提出e_pt-lgp的关系式,并通过三轴压缩试验的数据对提出的关系式加以验证。应用新的关系式计算不排水条件下试样的相变孔隙比e_pt,进而计算出模型中的相变状态参量。改进后的不排水本构模型的计算结果与不排水三轴压缩的试验结果能较好地吻合,即验证了本构模型的有效性,也验证了e_pt-lgp关系式的合理性,使原有的边界面本构模型更好地描述不排水的情况下、不同密度和围压状态下饱和砂土的力学行为。     

多壁碳纳米管基质固相分散萃取-HPLC法测定蔬菜中的啶虫脒残留

建立了以多壁碳纳米管（MWCNTs）为萃取剂的基质固相萃取（MSPD）、HPLC测定蔬菜中啶虫脒残留的方法。将样品与工业级碳纳米管、无水硫酸镁混合研磨后装柱,并用乙酸乙酯洗脱,高效液相色谱法测定。采用C8柱（3.0mm×100mm,1.8μm）分离,甲醇-水（3∶2,v/v）为流动相,流速0.10mL/min,紫外检测波长250nm,进样量2.5μL,柱温为30℃。结果表明,该方法对蔬菜样品中啶虫脒的回收率为84.0%¹06.0%,精密度为0.1%¹2.5%,方法最低检出限为0.0085mg/L。该法简便、快速、准确。      

RP-HPLC测定保加利亚乳杆菌腺苷酸方法的建立与应用

建立适用于测定保加利亚乳杆菌腺苷酸的反相高效液相色谱方法,为评价代谢组学研究中淬灭液的淬灭效果提供方法支持。采用SinoChrom ODS-BPC18色谱柱,甲醇-30mmol/L磷酸钾（V/V=5∶95）缓冲液（pH7.0）作为流动相,流速0.7mL/min,柱温25℃,紫外检测波长254nm。结果表明该方法具有较好的线性和较高的精密度,回收率在94.12%～109.6%之间。利用该方法测定了使用最广泛的60%（v/v）冷甲醇/水溶液淬灭保加利亚乳杆菌的效果,结果发现ATP的泄露率高达70.43%±2.3%,能荷值是0.42±0.015,从而推断该淬灭方案不但会造成胞内代谢物的大量泄漏,而且菌体的代谢反应也没有完全停止,故该淬灭方案不适合保加利亚乳杆菌。      

基于TSI方位估计的三维摄像声纳阵列幅相误差校正

针对水下三维摄像声纳系统的大型均匀矩形阵列, 提出了一种基于三步迭代(three-step-iteration, TSI)方位估计的幅相误差校正方法.该方法使用1个方位未知的远场校正源, 首先采用一种新的TSI方位估计算法, 获得对校正源方位的鲁棒估计;然后根据该方位估计结果和采样数据协方差矩阵, 估计阵列的幅相误差.利用该方法估计得到的幅相误差参数, 可使三维摄像声纳在存在阵列幅相误差的条件下仍提供良好的探测性能.通过仿真实验, 对该方法和基于数据协方差矩阵Toeplitz-block特性的方法进行了比较研究.实验结果表明:该方法能处理Toeplitzblock方法无法解决的大阵列相位误差问题, 同时小信噪比条件下的性能也有明显改善.     

气相色谱-质谱法分析比较传统同山高粱酒及其改良工艺酒样中的香气成分

采用顶空固相微萃取法（HS-SPME）提取传统清香型同山高粱酒及其经发酵工艺改良后的酒样Ⅰ、酒样Ⅱ中的香气成分,结合气相色谱-质谱联用仪对香气成分进行分析。结果显示,除乙醇外,三种清香型白酒中共检测出61种香气成分,其中:传统同山高粱酒中共检测出香气成分35种,主要呈香化合物有酯类化合物、醇类化合物和芳香族化合物,主要香气成分有己酸乙酯、乙酸乙酯、3-甲基丁醇、1,1-二乙氧基乙烷、丁酸乙酯;酒样Ⅰ中共检测出香气成分45种,主要呈香化合物有酯类化合物、醇类化合物、烷烃类化合物和烯烃类化合物,主要香气成分有乙酸乙酯、1,1-二乙氧基乙烷、3-甲基丁醇、双戊烯、十二烷;酒样Ⅱ中共检测出香气成分41种,主要呈香化合物有酯类化合物、烷烃类化合物、烯烃类化合物和芳香族化合物,主要香气成分有乙酸乙酯、1,1-二乙氧基乙烷、3-甲基丁醇、双戊烯、十四烷。研究结果表明,传统同山高粱酒经发酵工艺改良后,酒中香气成分种类明显增多,酒的口感和风味得到改善。      

激光填丝焊接镍基合金/304不锈钢二次相的转变机制及其对晶间腐蚀性能的影响

为了阐明激光填丝焊接镍基合金(Hastelloy C-276)/304二次相的转变机制和晶间腐蚀机制,通过EPMA和TEM对二次相进行分析;采用双环动电位再活化法(DL-EPR)对焊接接头的晶间腐蚀性能进行评价,并采用EDS对焊接接头腐蚀表面进行成分分析.实验结果表明:p相和μ相为完全共格关系,且其共格关系为[001]...     

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD

TAR DNA binding protein 43 (TDP-43) is a DNA/RNA binding protein involved in pivotal cellular functions, especially in RNA metabolism. Hyperphosphorylated and ubiquitinated TDP-43-positive neuronal cytoplasmic inclusions are identified in the brain and spinal cord in most cases of amyotrophic lateral sclerosis (ALS) and a substantial proportion of frontotemporal lobar degeneration (FTLD) cases. TDP-43 dysfunctions and cytoplasmic aggregation seem to be the central pathogenicity in ALS and FTLD. Therefore, unraveling both the physiological and pathological mechanisms of TDP-43 may enable the exploration of novel therapeutic strategies. This review highlights the current understanding of TDP-43 biology and pathology, describing the cellular processes involved in the pathogeneses of ALS and FTLD, such as post-translational modifications, RNA metabolism, liquid–liquid phase separation, proteolysis, and the potential prion-like propagation propensity of the TDP-43 inclusions.     

Highly Selective Electrochemical CO2 Reduction to C2 Products on a g-C3N4-Supported Copper-Based Catalyst

Herein, a novel approach used to enhance the conversion of electrochemical CO₂ reduction (CO₂R), as well as the capacity to produce C₂ products, is reported. A copper oxide catalyst supported by graphite phase carbon nitride (CuO/g-C₃N₄) was prepared using a one-step hydrothermal method and exhibited a better performance than pure copper oxide nanosheets (CuO NSs) and spherical copper oxide particles (CuO SPs). The Faradaic efficiency reached 64.7% for all the C₂ products, specifically 37.0% for C₂H₄, with a good durability at −1.0 V vs. RHE. The results suggest that the interaction between CuO and the two-dimensional g-C₃N₄ planes promoted CO₂ adsorption, its activation and C-C coupling. This work offers a practical method that can be used to enhance the activity of electrochemical CO₂R and the selectivity of C₂ products through synergistic effects.     

High Monocyte Count Associated with Human Cytomegalovirus Replication In Vivo and Glucocorticoid Therapy May Be a Hallmark of Disease

Cytomegalovirus (CMV) syndrome and infectious disease are defined as pathogen detection with appropriate clinical symptoms, but there are not pathognomonic signs of CMV disease. Although the prodrome of acute minor viral infections leukopenia (lymphopenia and neutropenia) is noted with onset of fever, followed by monocytosis, the role of monocytosis in CMV disease has not been described. Furthermore, under influence of corticosteroid therapy, CMV reactivation and monocytosis are described, but without a strict relationship with steroids dose. In the study, the monocyte level was investigated during the CMV infectious process. Regrettably, a non-selected group of 160 patients with high CMV viremia showed high dispersion of monocyte level and comparable with the median value for healthy subjects. Therefore, we investigated monocyte level in CMV-infected patients in relation to the logarithmic phase of the infectious process. Samples from patients with active CMV replication (exponential growth of CMV viremia) were tested. Significant monocytosis (above 1200/µL) during the logarithmic phase of CMV infection (with exponent between 3.23 and 5.77) was observed. Increased count and percentage of monocytes correlated with viral replication in several clinical situations except when there was a rapid recovery without relapse. Furthermore, glucocorticoids equivalent to 10 and 20 mg of dexamethasone during a 2–3-week period caused monocytosis—significant increase (to 1604 and 2214/µL, respectively). Conclusion: In light of the logarithmic increase of viral load, high monocytosis is a hallmark of CMV replication. In the COVID-19 era, presence of high virus level, especially part of virome (CMV) in the molecular technique, is not sufficient for the definition of either proven or probable CMV replication at any site. These preliminary observations merit additional studies to establish whether this clinical response is mediated by monocyte production or by decrease of differentiation to macrophages.     

Engineering Bio-Adhesives Based on Protein–Polysaccharide Phase Separation

Glue-type bio-adhesives are in high demand for many applications, including hemostasis, wound closure, and integration of bioelectronic devices, due to their injectable ability and in situ adhesion. However, most glue-type bio-adhesives cannot be used for short-term tissue adhesion due to their weak instant cohesion. Here, we show a novel glue-type bio-adhesive based on the phase separation of proteins and polysaccharides by functionalizing polysaccharides with dopa. The bio-adhesive exhibits increased adhesion performance and enhanced phase separation behaviors. Because of the cohesion from phase separation and adhesion from dopa, the bio-adhesive shows excellent instant and long-term adhesion performance for both organic and inorganic substrates. The long-term adhesion strength of the bio-glue on wet tissues reached 1.48 MPa (shear strength), while the interfacial toughness reached ~880 J m⁻². Due to the unique phase separation behaviors, the bio-glue can even work normally in aqueous environments. At last, the feasibility of this glue-type bio-adhesive in the adhesion of various visceral tissues in vitro was demonstrated to have excellent biocompatibility. Given the convenience of application, biocompatibility, and robust bio-adhesion, we anticipate the bio-glue may find broad biomedical and clinical applications.